Cheng P.-N.Mo L.-R.Chen C.-T.Chen C.-Y.Huang C.-F.Kuo H.-T.Lo C.-C.Tseng K.-C.Huang Y.-H.Tai C.-M.Peng C.-Y.Bair M.-J.Chen C.-H.Yeh M.-L.Lin C.-L.Lin C.-Y.Lee P.-L.Chong L.-W.Hung C.-H.Chang T.S.Huang J.-F.Yang C.-C.Hu J.-T.Lin C.-W.Wang C.-C.Su W.-W.Hsieh T.-Y.Lin C.-L.Tsai W.-L.Lee T.-H.Chen G.-Y.Wang S.-J.Chang C.-C.Yang S.-S.Wu W.-C.Huang C.-S.Chou K.-H.Kao C.-N.Tsai P.-C.CHEN-HUA LIULee M.-H.Cheng C.-Y.Tsai M.-C.CHUN-JEN LIUDai C.-Y.Lin H.-C.JIA-HORNG KAOChuang W.-L.Yu M.-L.TACR investigators2022-10-132022-10-1320222193-8229https://www.scopus.com/inward/record.uri?eid=2-s2.0-85122256113&doi=10.1007%2fs40121-021-00576-7&partnerID=40&md5=884c4f03d431a9e71a413e062f87e3d1https://scholars.lib.ntu.edu.tw/handle/123456789/623517[SDGs]SDG3Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwanjournal article10.1007/s40121-021-00576-72-s2.0-85122256113